Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Better Buy: AbbVie vs. Merck


There are plenty of reasons for investors to like big pharma stocks. They're usually resilient during economic downturns. Many of them have solid growth prospects. And nearly all of them pay dividends.

AbbVie (NYSE: ABBV) and Merck (NYSE: MRK) rank as two of the biggest of the big pharmaceutical companies. These two companies face unique challenges and opportunities. But which is the better pick for long-term investors?

Image source: Getty Images.

Continue reading


Source Fool.com

Like: 0
Share

Comments